EGFR and lung cancer: The multivariate Cox proportional hazards analysis adjusted for EGFR mutation status, pathological stage, histological type, and adjuvant chemotherapy revealed that postoperative recurrence of lung cancer was 4.8 times as likely to occur with a PD-L1-high expression status in comparison to PD-L1-negative cases.